May Health develops an innovative solution for Polycystic Ovary Syndrome (PCOS) related infertility.
May Health has raised $24.8M in total funding. The most recent round was Series B. The last funding was announced in May 2024.
May Health's investors include Bpifrance, Sofinnova Partners, Trill Impact, Avestria Ventures, MedTech Innovator.
May Health is headquartered in Paris, France.
May Health develops an innovative solution for Polycystic Ovary Syndrome (PCOS) related infertility.
May Health is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"May Health — Funding & Investors." VCBacked, May 13, 2024, https://www.vcbacked.co/company/may-health. Accessed October 24, 2026.
VCBacked. (2024). May Health — Funding & Investors. Retrieved October 24, 2026, from https://www.vcbacked.co/company/may-health
{{cite web |title=May Health — Funding & Investors |url=https://www.vcbacked.co/company/may-health |website=VCBacked |access-date=October 24, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated